statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Contrasting Elutia (NASDAQ:ELUT) & CG Oncology (NASDAQ:CGON)

Elutia (NASDAQ:ELUT  Get Free Report) and CG Oncology (NASDAQ:CGON  Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses...

Head to Head Survey: Elutia (NASDAQ:ELUT) vs. Pluri (NASDAQ:PLUR)

Elutia (NASDAQ:ELUT  Get Free Report) and Pluri (NASDAQ:PLUR  Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two...

Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM  Clearance Decision in First Half of 2024

SILVER SPRING, Md., March 07, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ( Elutia or the Company ) today provided a business update and reported financial results for the fourth quarter...

Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024

SILVER SPRING, Md., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ( Elutia ), a company pioneering drug-eluting biomatrix products, today announced that it will release its fourth...

Elutia Inc.'s (NASDAQ:ELUT) Share Price Is Matching Sentiment Around Its Revenues

You may think that with a price-to-sales (or "P/S") ratio of 1.5x Elutia Inc. ( NASDAQ:ELUT ) is definitely a stock...

Elutia management to meet with Lake Street

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Elutia's CanGarooRM: Pioneering Drug-Eluting Biologic for Secure Medical Implants

Elutia's CanGarooRM: Pioneering Drug-Eluting Biologic for Secure Medical Implants...

Elutia Regains Compliance with Nasdaq Listing Requirements

SILVER SPRING, Md., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) today announced that it has regained compliance with Nasdaq's market value of listed securities requirement and...

Elutia, Inc. operates as a biotechnology company. It develops biologic products to improve compatibility between medical devices and the patients who need them. The firm operates through the following segments: Device Protection, Women’s Health, Orthobiologics and Cardiovascular. The Device Protection segment includes biological envelope that remodels into systematically connected, vascularized tissue for the long-term pocket protection of certain cardiac and neurostimulator implantable electronic vehicles. The Women’s Health segment includes pre-hydrated, human acellular dermal matrix, or HADM, that is designed to enable rapid integration, cellular repopulation and rapid revascularization at the surgical site. The Orthobiologics segment includes a variety of viable matrices, produced with a proprietary process that is designed to protect and preserve native bone cells and reduce programmable cell death, for use in bone repair and fusion procedures. The Cardiovascular segment includes a portfolio of extracellular matrices that retain the natural composition of collagen, growth factors and proteins for use in vascular and cardiac repair and pericardial closure. The company was founded by Kevin L. Rakin and Charles Randal Mills on August 6, 2015 and is headquartered in Silver Spring, MD.

Volume	69,893.00
52-Wk High	$5.24
52-Wk Low	$1.10

ELUT Elutia Inc - Ordinary Shares - Class A

About

Feed

News

Sentiment

Earnings

Fundamentals